The court has imposed a firm deadline of December 11, 2024, for defendants to complete the production of custodial files as previously ordered on October 7, 2024. The judge has [...]
This week, there’s a significant development in the ongoing Valsartan multi-district litigation (MDL). The judge overseeing the case has selected five plaintiffs’ lawsuits to proceed to the next round of [...]
On December 16, 2024, the federal judge overseeing the Valsartan litigation confirmed the selection of five cases for the second set of bellwether trials. These trials are part of the [...]
After the postponement of the first lawsuit selected for a bellwether trial, a new case has been scheduled to kick off the trials. The first trial will now involve a [...]
As the first bellwether trial in the Valsartan multi-district litigation (MDL) draws near, we are seeing an increase in interest surrounding the case. This is a common development, and we [...]
As we await the appellate court's decision on the dismissal of the Tylenol and autism MDL, new claims continue to be filed in state courts nationwide. If your child has [...]
The appeal challenging the dismissal of the Tylenol autism and ADHD MDL is now underway. Plaintiffs argue that Judge Cote improperly excluded expert testimony linking Tylenol use during pregnancy to [...]
After the dismissal of the federal MDL in August, plaintiffs' lawyers have turned to appeal as their last option. We will provide updates on the appellate filing as soon as [...]
On August 20, 2024, Judge Cote officially dismissed all cases in the Tylenol Autism Multidistrict Litigation, following her July ruling. Plaintiffs' counsel has filed an appeal, but if the appeal [...]
A new lawsuit has been filed by a plaintiff from Madison, Indiana, who claims that the makers of Suboxone failed to warn users about the drug’s severe dental damage risks. [...]
